Answers are grounded in this paper and cite their sources.
Expanding cannabis legislation may increase access to and use of Cannabis sativa products containing delta-9-tetrahydrocannabinol ( Δ9- THC) and cannabidiol (CBD) among pregnant and breastfeeding individuals, raising concerns about developmental and reproductive toxicity (DART), developmental neurotoxicity (DNT), and endocrine disruption. Populations with limited access to prenatal care, reliable health information, or regulated cannabis products may experience greater exposure uncertainty. We evaluated new approach methodologies (NAMs) to investigate potential developmental and pregnancy-related hazards associated with Δ9- THC, CBD, and selected pesticide contaminants used in cannabis production. NAMs, including the Generalized Read-Across (GenRA) tool, the Toxicity Estimation Software Tool (TEST), Cheminformatics, Predicting Developmental Toxicity Potential Project (PredPreg), and OrbiTox, were used to predict DART, DNT, and endocrine disruption potential for Δ9- THC, CBD, and the pesticide contaminants chlorfenapyr (CFP), trifloxystrobin (TRI), and piperonyl butoxide (PBO). ToxCast data were used as inputs for Integrated Chemical Environment adult and maternal/fetal physiologically based toxicokinetic (PBTK) models to generate adjusted administered equivalent dose (AdjAED) estimates, which were compared with available in vivo points of departure. Each NAM identified potential DART- and DNT-related hazards for the five chemicals. ToxCast results supported the biological plausibility of developmental and endocrine effects across all chemicals. Adult and fetal PBTK-predicted AdjAEDs generally agreed within an order of magnitude with measured in vivo points of departure. Overall findings demonstrate that open-access NAMs can identify potential developmental hazards associated with Δ9- THC, CBD, and pesticide contaminants while addressing data gaps, prioritize chemicals for further investigation, and inform future studies. Results highlight the importance of reducing exposure uncertainty and improving prenatal risk communication.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: